Daxas vs Otezla: Side-by-Side Comparison
Quick answer: Daxas and Otezla are both phosphodiesterase-4 (pde4) inhibitor used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Daxas | Otezla |
|---|---|---|
| Drug class | Phosphodiesterase-4 (PDE4) inhibitor | Phosphodiesterase-4 (PDE4) inhibitor |
| ATC code | R03DX07 | L04AA32 |
| Primary indications | Severe COPD with chronic bronchitis and history of exacerbations | Plaque psoriasis, Psoriatic arthritis |
| Mechanism | Roflumilast selectively inhibits PDE4, increasing intracellular cAMP and reducing airway inflammation | Apremilast selectively inhibits PDE4, increasing intracellular cAMP and modulating pro-inflammatory and anti-inflammatory cytokine production |
| Common dose | 500 mcg orally once daily | 30 mg twice daily (after titration) |
| Detail page | Daxas details → | Otezla details → |
How to choose between Daxas and Otezla
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Phosphodiesterase-4 (PDE4) inhibitor on iMedic · Daxas full details · Otezla full details
Frequently asked questions
Is Daxas better than Otezla?
Neither is universally 'better.' They are both phosphodiesterase-4 (pde4) inhibitor with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Daxas to Otezla?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Daxas and Otezla have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Daxas and Otezla available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.